Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2, 2, 3, 3, 3-pentafluoropropyl) acetamide]

British Journal of Cancer

Volumn 72, Issue 4, 1995, Pages 875-882

  Evans, S M ^a   Joiner, B ^b   Jenkins, W T ^b   Laughlin, K M ^b   Lord, E M ^c   Koch, C J ^b  

^a School of Veterinary Medicine   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

9L; Flow cytometry; Fluorescence; Hypoxia; Nitroimidazole; Tumour

Indexed keywords

ACETAMIDE DERIVATIVE; EOSIN; FLUOROCHROME; HEMATOXYLIN; MONOCLONAL ANTIBODY; NITROIMIDAZOLE DERIVATIVE; NITROREDUCTASE; OXYGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL HYPOXIA; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GLIOMA; IMAGING; MEMBRANE BINDING; MICROSCOPY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; STOMACH TUMOR; TISSUE SECTION; TUMOR CELL;

ANIMAL; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CELL HYPOXIA; ETANIDAZOLE; FLUORESCENCE; GLIOMA; HYDROCARBONS, FLUORINATED; RADIATION-SENSITIZING AGENTS; RATS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028784382     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1995.427     Document Type: Article

References (37)

1. BROWN JM, AND GIACCI AJ. (1994). Tumor hypoxia: the picture has changed in the 1990’s. Int. J. of Radiation Biology, 65, 95–102.
2. CHAPLIN DJ, DURAND RE, AND OLIVE PL. (1986). Acute hypoxia in tumors: Implications for modifiers of radiation effects. Int. J. Rad. Oncol. Biol. Phys., 12, 1279–1282.
3. CHAPMAN JD, BAER K, AND LEE J. (1983). Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells. Cancer Res., 43, 1523–1528.
4. CLINE JM, THRALL DE, ROSNER GL, AND RALEIGH JA. (1994). Distribution of the hypoxia marker CCI-103F in canine tumors. Int. J. Radiat. Oncol. Biol. Phys., 28, 921–933.
5. EVANS SM, AND KOCH CJ. (1994). Characterization of the 9L glioma as a tissue isolated epigastric implant. Radiat. Oncol. Invest., 2, 134–143.
6. FRANKO AJ, KOCH CJ, GARRECHT BM, SHARPLIN J, AND HUGHES D. (1987). Oxygen dependence of binding of misonidazole to rodent and human tumors in vitro. Cancer Res., 47, 5367–5376.
7. FRANKO AJ, KOCH CJ, AND BOISVERT DPJ. (1992). Distribution of misonidazole adducts in 9L gliosarcoma tumors and spheroids: Implications for oxygen distribution. Cancer Res., 52, 1–7.
8. GRAY LH, CONGER AD, EBERT M, HORNSEY S, AND SCOTT OCA. (1953). Concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br. J. Radiol., 26, 638–648.
9. GUTIN PH, BARCELLOS MH, SHRIEVE DC, SANO Y, BERNSTEIN M, AND DEEN DF. (1982). Further evidence for the absence of a hypoxic fraction in the 9L rat tumor muticell spheroid system. Br. J. Cancer, 55, 688–690.
10. HODGKISS RJ, JONES G, LONG A, PARRICK J, SMITH KA, STRATFORD MRL, AND WILSON GD. (1991). Flow cytometric evaluation of hypoxic cells in solid experimental tumours using fluorescence immunodetection. Br. J. Cancer, 63, 119–125.
11. HODGKISS RJ, MIDDLETON RW, PARRICK J, RAMI HK, WARDMAN P, AND WILSON GD. (1992a). Bioreductive fluorescent markers for hypoxic cells: A study of 2-nitroimidazoles with substituents containing fluorescent, bridgehead-nitrogen, bicyclic systems. J. Med. Chem., 35, 1920–1926.
12. HODGKISS RJ, KELLEHER E, AND PARRICK J. (1992b). Hypoxia-specific inhibition of recovery from radiation damage by a novel nitroimidazole with a theophylline side chain. Int. J. Radiat. Biol., 61, 797–804.
13. HOWELL RL, AND KOCH CJ. (1980). The disaggregation, separation and identification of cells from irradiated and unirradiated EMT6 mouse tumors. Int. J. Radiat. Oncol. Biol. Phys., 6, 311–318.
14. KOCH CJ, GIANDOMENICO AR, AND LEE IYENGAR CW. (1993). Bioreductive metabolism of AF-2 [2(2-furyl)-3-(5-nitro-2-furyl)-acrylamide] combined with 2-nitroimidazole radiosensitizing agents. Biochem. Pharmacol., 46, 1029–1036.
15. KOCH CJ, EVANS SM, AND LORD EM. (1995a). Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-lH-imidazol-l-yl)-N-(2, 2,-3, 3, 3-pentafluoropropyl) acetamide]: Analysis of drug adducts by fluorescent antibodies vs bound radioactivity. Br. J. Cancer, 72, 865–870.
16. KOCH CJ, EVANS SM, AND LORD EM. (1995b). Comment on the hypothesis that hyperthermia facilitates reoxygenation. Int. J. Hyperthermia, 2, 447–450.
17. LAUGHLIN KM, EVANS SM, LORD EM, AND KOCH CJ. (1995). Biodistribution of the nitroimidazole EF5 (2-[2-nitro-lh-imidazoll-yl]-n-(2, 2, 3, 3, 3-pentafluoropropyl) acetamide) in mice bearing subcutaneous EMT6 tumors. Journal of Pharmacology and Experimental Therapeutics, (submitted).
18. LEITH JT, SCHILLING WA, AND WHEELER KT. (1975). Cellular radiosensitivity of a rat brain tumor. Cancer, 35, 1545–1550.
19. LOEFFLER DA, KENG PC, BAGGS RB, AND LORD EM. (1990). Lymphocyte infiltration and cytotoxicity under hypoxic conditions in the EMT6 mouse mammary tumor. Int. J. Cancer, 45, 462–467.
20. LORD EM, HARWELL L, AND KOCH CJ. (1993). Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. Cancer Res., 53, 5271–5276.
21. MACDONALD HR, AND KOCH CJ. (1977). Energy metabolism and T cell mediated cytolysis I. Synergism between inhibitors of respiration and glycolysis. J. Exp. Med., 146, 698–709.
22. MOULDER JE, AND ROCKWELL SC. (1984). Hypoxic fractions of solid tumors: experimental techniques, methods of analysis and a survey of existing data. Int. J. Radiat. Oncol. Biol. Phys., 10, 695–712.
23. MUSCHEL RJ, BERNHARD E, GARZA L, MCKENNA WG, AND KOCH CJ. (1995). Induction of apoptosis under hypoxic conditions. Cancer Res., 55, 995–998.
24. NATHAN CF, MERCER-SMITH JA, DESANTIS NM, AND PALLADINO MA. (1982). Role of oxygen in T cell mediated cytolysis. J. Immunol., 129, 2164–2171.
25. OLESON JR. (1995). Hyperthermia from the clinic to the laboratory: An Hypothesis. Int. J. Hyperthermia, 2, 315–322.
26. OLIVE PL, AND DURAND RE. (1983). Fluorescent nitroheterocycles for identifying hypoxic cells. Cancer Res., 43, 3276–3280.
27. RALEIGH JA, MILLER GG, FRANKO AJ, KOCH CJ, FUCIARELLI AF, AND KELLEY DA. (1987). Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours. Br. J. Cancer, 56, 395–400.
28. SECOMB TW, HSU R, DEWHIRST MW, KLITZMAN B, AND GROSS JF. (1993). Analysis of oxygen transport to tumor tissue by microvascular networks. Int. J. Radiat. Oncol. Biol. Phys., 25, 481–489.
29. STONE HB, BROWN MJ, PHILLIPS TL, AND SUTHERLAND RM. (1993). Oxygen in human tumors: correlations between methods of measurement and response to therapy. Radiat. Res., 136, 422–434.
30. TEICHER BA, HERMAN TS, AND ROSE CM. (1988). Effect of Fluosol-DA on the response of intracranial 9L tumors to X-rays and BCNU. Int. J. Radiat. Oncol. Biol. Phys., 15, 1187–1192.
31. THOMLINSON RH, AND GRAY LH. (1955). The histological structure of some human lung cancers and the possible implications for radiotherapy. Br. J. Cancer, 9, 539–579.
32. THOMPSON JM, GRALOW JR, LEVY R, AND MILLER RA. (1985). The optimal application of forward and ninety degree light scatter in flow cytometry for the gating of mononuclear cells. Cytometry, 6, 401–406.
33. URTASUN RC, CHAPMAN JD, RALEIGH JA, FRANKO AJ, AND KOCH CJ. (1986). Binding of 3H-Misonidazole to solid human tumors as a measure of tumor hypoxia. Int. J. Radiat. Oncol. Biol. Phys., 12, 1263–1267.
34. WALLEN CA, MICHAELSON SM, AND WHEELER KT. (1980). Evidence for an unconventional radiosensitivity of rat 9L subcutaneous tumors. Radiat. Res., 85, 529–541.
35. WEBER T, SEITZ RJ, LIEBERT UG, GALLISH E, AND WECHSLER W. (1985). Affinity cytochemistry of vascular endothelia in brain tumors by biotinylated Ulex Europaeus Type I Lectin (UEA I). Acta Neuropathol. (Berl), 67, 128–135.
36. WONG KH, WALLEN CA, AND WHEELER KT. (1990). Chemosensitization of the nitrosoureas by 2-nitroimidazoles in the subcutaneous 9L tumor model: Pharmacokinetic and structure activity considerations. Int. J. Radiat. Biol. Oncol. Phys., 18, 1043–1050.
37. ZEMAN EM, CALKINS DP, CLINE JM, THRALL DE, AND RALEIGH JA. (1993). The relationship between proliferative and oxygenation status in spontaneous canine tumors. Int. J. Radiat. Oncol. Biol. Phys., 27, 891–898.